Biotech & Health Tech
Bayer CEO says company is ‘working on’ MFN in the US
Bayer CEO Bill Anderson said the drugmaker is “working on” a most favored nation agreement, signaling that it is in talks with President Donald Trump’s administration. The German drugmaker was not part ...
Bayer CEO Bill Anderson said the drugmaker is “working on” a most favored nation agreement, signaling that it is in talks with President Donald Trump’s administration. The German drugmaker was not part ...
This is a summary of the story. Read the full article at Endpoints News (Biopharma) ↗